Petmed Express (NASDAQ:PETS) Stock Rating Lowered by Craig Hallum
Craig Hallum lowered shares of Petmed Express (NASDAQ:PETS) from a buy rating to a hold rating in a report released on Friday morning, BenzingaRatingsTable reports. They currently have $15.00 price objective on the stock.
Separately, BidaskClub upgraded shares of Petmed Express from a sell rating to a hold rating in a research report on Thursday, August 1st.
Petmed Express stock opened at $16.84 on Friday. Petmed Express has a 52 week low of $15.00 and a 52 week high of $38.90. The firm’s 50-day simple moving average is $16.08 and its 200 day simple moving average is $19.55. The firm has a market capitalization of $345.31 million, a PE ratio of 10.60 and a beta of 0.54.
The firm also recently disclosed a quarterly dividend, which was paid on Friday, August 9th. Investors of record on Friday, August 2nd were given a $0.27 dividend. The ex-dividend date of this dividend was Thursday, August 1st. This represents a $1.08 annualized dividend and a dividend yield of 6.41%.
Institutional investors have recently added to or reduced their stakes in the stock. Geode Capital Management LLC increased its holdings in shares of Petmed Express by 5.2% in the 4th quarter. Geode Capital Management LLC now owns 241,812 shares of the company’s stock worth $5,624,000 after buying an additional 11,956 shares during the last quarter. Metropolitan Life Insurance Co. NY increased its holdings in shares of Petmed Express by 335.9% in the 4th quarter. Metropolitan Life Insurance Co. NY now owns 6,199 shares of the company’s stock worth $144,000 after buying an additional 4,777 shares during the last quarter. Municipal Employees Retirement System of Michigan bought a new stake in shares of Petmed Express in the 4th quarter worth about $139,000. Deutsche Bank AG increased its holdings in shares of Petmed Express by 166.1% in the 4th quarter. Deutsche Bank AG now owns 329,962 shares of the company’s stock worth $7,673,000 after buying an additional 205,960 shares during the last quarter. Finally, Eqis Capital Management Inc. bought a new stake in shares of Petmed Express in the 1st quarter worth about $341,000. Institutional investors and hedge funds own 94.69% of the company’s stock.
About Petmed Express
PetMed Express, Inc and its subsidiaries, doing business as 1-800-PetMeds, operates as a pet pharmacy in the United States. It markets prescription and non-prescription pet medications, and other health products for dogs and cats directly to the consumers. The company offers non-prescription medications and supplies, including flea and tick control products, bone and joint care products, vitamins, treats, nutritional supplements, hygiene products, and supplies; and prescription medications, such as heartworm preventative, flea and tick preventative, arthritis, thyroid, diabetes, pain, heart/blood pressure, and other specialty medications, as well as generic substitutes.
Featured Story: Convertible Shares
Receive News & Ratings for Petmed Express Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Petmed Express and related companies with MarketBeat.com's FREE daily email newsletter.